The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kardashian R.A.

Peoples’ Friendship University of Russia named after Patrice Lumumba, Medical Institute

Efremov A.A.

Central State Medical Academy of the Department of Presidential Affairs of the Russian Federation

Nikiforov I.A.

Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency

Korovyakov A.V.

Psychiatric Clinical Hospital No.13

Factors influencing the achievement of remission in patients with alcohol dependence and concomitant psychological disorders

Authors:

Kardashian R.A., Efremov A.A., Nikiforov I.A., Korovyakov A.V.

More about the authors

Read: 1002 times


To cite this article:

Kardashian RA, Efremov AA, Nikiforov IA, Korovyakov AV. Factors influencing the achievement of remission in patients with alcohol dependence and concomitant psychological disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(6):21‑30. (In Russ.)
https://doi.org/10.17116/jnevro202512506121

Recommended articles:
Clinical and immu­nological rela­tionships in patients with early schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):35-42
Modern concepts of sleep disturbances asso­ciated with mental diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):7-12
Quantitative electroencephalogram in fema­les at different stages of alco­hol remi­ssion. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):122-126
Effe­cts of sema­glutide on mental health. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):28-36

References:

  1. Zobin ML. Harm reduction in alcohol problems: expanding treatment options (II). Nevrologicheskii vestnik. 2014;1:65-73. (In Russ.).
  2. Mattisson C, Bogren M, Horstmann V, et al. Remission from Alcohol Use Disorder among Males in the Lundby Cohort during 1947-1997. Research Article. Psychiatry journal. 2018;2018:4829389. https://doi.org/10.1155/2018/4829389
  3. Hagman BT, Falk D, Litten R, Koob GF. Defining Recovery From Alcohol Use Disorder: Development of an NIAAA Research Definition. Am J Psychiatry. 2022;179(11):807-813.  https://doi.org/10.1176/appi.ajp.21090963
  4. World Health Organization (WHO) Global Status Report on Alcohol and Health 2018. Geneva, Switzerland: WHO; 2018.
  5. Williams EC, Matson TE, Harris AHS. Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions. Addict Sci Clin Pract. 2019;14:6.  https://doi.org/10.1186/s13722-019-0134-8
  6. Diagnostic and Statistical Manual of Mental Disorders: DSM-V. Fifth Edition. Washington, DC: American Psychiatric Association. 2013;947. 
  7. Sliedrecht W, Roozen H, de Waart R, et al. Variety in Alcohol Use Disorder Relapse Definitions: Should the Term «Relapse» Be Abandoned? J. Stud. Alcohol Drugs. 2022;83(2):248-259. 
  8. Maisto SA, Hallgren KA, Roos CR, et al. Patterns of transitions between relapse to and remission from heavy drinking over the first year after outpatient alcohol treatment and their relation to long-term outcomes. J. Consult. Clin. Psychol. 2020;88(12):1119-1132. https://doi.org/10.1037/ccp0000615
  9. Koenig LB, Haber JR, Jacob T, et al. Transitions in alcohol use over time: a survival analysis. BMC Psychol. 2020;8(1):115.  https://doi.org/10.1186/s40359-020-00479-1
  10. Stephen Rich J, Martin PR. Co-occurring psychiatric disorders and alcoholism. Handb Clin Neurol. 2014;125:573-88.  https://doi.org/10.1016/B978-0-444-62619-6.00033-1
  11. Egorov AY, Shagiakhmetov FSh. How to treat a narcological patient with a double diagnosis? Obozrenie psikhiatrii i meditsinskoi psikhologii imeni V.M. Bekhtereva. 2016(2):61-77. (In Russ.).
  12. Sivolap YuP, Savchenkov VA, Yanushkevich MV. Double diagnosis as a therapeutic problem. Voprosy narkologii. 2017;6(154):105-108. (In Russ.).
  13. Polyansky DA, Kozhinova TA and Nemkova TI. Peculiarities of the interaction of alcohol dependence and mental disorders of the schizophrenic spectrum. Sotsial’naya i klinicheskaya psikhiatriya. 2022;32(2):95-100. (In Russ.).
  14. Brennan PL, Schutte KK, Moos RH. Patterns and predictors of late-life drinking trajectories: a 10-year longitudinal study. Psychol Addict Behav. 2010;24(2):254-264.  https://doi.org/10.1037/a0018592
  15. Han SY, Cho MJ, Won S, et al. Sociodemographic Factors and Comorbidities Associated with Remission from Alcohol Dependence: Results from a Nationwide General Population Survey in Korea. Psychiatry Investig. 2015;12(3):316-23.  https://doi.org/10.4306/pi.2015.12.3.316
  16. Rybakova KV. Algorithm of diagnosis of comorbid mental disorders in alcohol dependence. Voprosy narkologii. 2018;1(161):18-28. (In Russ.).
  17. Hoffman AG, Ponizovsky PA. On the combination of mental illness with alcohol dependence. Voprosy narkologii. 2018;162(2):102-113. (In Russ.).
  18. Torrens M, Adan A. Recent Advances in Dual Disorders (Addiction and Other Mental Disorders). J. Clin. Med. 2023;12(9):3315. https://doi.org/10.3390/jcm12093315
  19. Bjarko VV, Skandsen T, Moen KG, et al. Time of Injury and Relation to Alcohol Intoxication in Moderate-to-Severe Traumatic Brain Injury: A Decade-Long Prospective Study. World Neurosurg. 2019;122:e684-e689. https://doi.org/10.1016/j.wneu.2018.10.122
  20. Weil ZM, Karelina K, Corrigan JD. Does pediatric traumatic brain injury cause adult alcohol misuse: Combining preclinical and epidemiological approaches. Exp. Neurol. 2019;317:284-290.  https://doi.org/10.1016/j.expneurol.2019.03.012
  21. Petrova NN, Khvostikova DA. Prevalence, structure, and risk factors for mental disorders in older adults. Dostizheniya v Gerontologii. 2021;34(1):152-159. (In Russ.).
  22. Dervaux A, Laqueille X. Comorbidités psychiatriques de l’alcoolodépendance. Presse Med. 2018;47(6):575-585.  https://doi.org/10.1016/j.lpm.2018.01.005
  23. Galperin YaG. Some clinical features of the period of therapeutic remission of patients with chronic alcoholism. Voprosy kliniki i sovremennoy terapii psikhicheskikh zabolevaniy. Moscow, 1971:371-376. (In Russ.).
  24. Darenskiy ID. Evaluation of the phase course of alcoholism. S.S. Korsakov Journal of Neurology and Psychiatry. 1998;10:12-16. (In Russ.).
  25. Yeryshev OF, Rybakova TG, Shabanov PD. Alkogol’naya zavisimost’: Formirovanie. Techenie. Protivorecidivnaya terapiya. Saint Petersburg: EHLBI-SPb., 2002. 189 s. (In Russ.).
  26. Shaidukova LK. Remission disorders in patients with alcoholism. Kazanskiy meditsinskiy zhurnal. 2002;83(2):114-118. (In Russ.).
  27. Besedina OB, Kornilov AA. Formation of remissions in alcohol dependence in conditions of penitentiary institutions. Sibirskiy vestnik psikhiatrii i narkologii. 2006;1:49-51. (In Russ.).
  28. Ibatov AN, Bazhin AA. Clinical variants of neuropsychiatric disorders in remission in chronic alcoholism. S.S. Korsakov Journal of Neurology and Psychiatry. 1999;92(2):91-93. (In Russ.).
  29. Shulkin LM, Kosenko NA, Kosenko VG, et al. Clinical review of alcohol dependence remission. Kubanskij nauchnyj medicinskij vestnik. 2015;2(151):154-161. (In Russ.).
  30. Bolotova ZN, Artemchuk AF, Manuylenko YuA. Forecasting the duration of therapeutic remission, clinical and social and labor rehabilitation of patients with chronic alcoholism. Mediko-biologicheskie problemy alkogolizma. Moscow, 1988:140-144. (In Russ.).
  31. Alkogolizm: Rukovodstvo dlya vrachej. Edited by N.N. Ivanets, M.A. Vinnikova. Moscow: A50 LLC «Publishing House «Medical Information Agency», 2011. 856 p. (In Russ.).
  32. Ibragimova Sh. Kh. Klinicheskaya harakteristika epizodov obostreniya patologicheskogo vlecheniya k alkogolyu v remissiyah u bol’nyh alkogolizmom. Aktual’nye voprosy psihiatrii i narkologii. Edited by prof. M.G. Gulyamov. Dushanbe: Publishing House of the Central Committee of the Communist Party of Tajikistan, 1991:112-113. (In Russ.).
  33. Kardashyan RA, Pronin VYu, Medvedev VE. Organic mental disorders with comorbid alcoholism in the elderly. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(12):27-33. (In Russ.). https://doi.org/10.17116/jnevro202312312127
  34. Skvira IM. Clinical structure of alcohol dependence remission. Problemy zdorov’ya i ekologii. 2019;3(61):17-24. (In Russ.). URL: https://cyberleninka.ru/article/n/klinicheskaya-struktura-remissii-alkogolnoy-zavisimosti
  35. Agibalova TV, Nobatova VN, Tuchina OD, et al. Review of Factors Affecting Remission in Narcological Patients. Rossijskij mediko-biologicheskij vestnik imeni akademika I.P. Pavlova. 2023;31(1):1559-163. (In Russ.). https://doi.org/10.17816/PAVLOVJ105809
  36. Trim RS, Schuckit MA, Smith TL. Predictors of initial and sustained remission from alcohol use disorders: Findings from the 30-Year follow-up of the San Diego Prospective Study. Alcoholism: Clinical and Experimental Research. 2013;37(8):1424-1431. https://doi.org/10.1111/acer.12107
  37. McCabe SE, Cranford JA, Boyd CJ. Stressful events and other predictors of remission from drug dependence in the United States: Longitudinal results from a national survey. Journal of Substance Abuse Treatment. 2016;71:41-47.  https://doi.org/10.1016/j.jsat.2016.08.008
  38. Ritz L, Coulbault L, Lannuzel C, et al. Clinical and Biological Risk Factors for Neuropsychological Impairment in Alcohol Use Disorder. PLoS One. 2016;11(9):e0159616. https://doi.org/10.1371/journal.pone.0159616
  39. Raabe FJ, Wagner E, Weiser J, et al. Classical blood biomarkers identify patients with higher risk for relapse 6 months after alcohol withdrawal treatment. European Archives of Psychiatry and Clinical Neuroscience. 2021;271(5):891-902.  https://doi.org/10.1007/s00406-020-01153-8
  40. Tsygankov BD, Klyachin IA, Shamov SA, et al. Clinical and psychological characteristics of patients with alcoholic remission and alcoholic relapse. Vestnik nevrologii, psihiatrii i nejrohirurgii. 2019;9:3-8. (In Russ.).
  41. Pandey S, Bolstad I, Lien L, et al. Antisocial Personality Disorder among Patients in Treatment for Alcohol Use Disorder (AUD): Characteristics and Predictors of Early Relapse or Drop-Out. Substance Abuse and Rehabilitation. 2021;12:11-22.  https://doi.org/10.2147/SAR.S296526
  42. Nagaich N, Radha S, Neeraj G, et al. Factors affecting remission and relapse in alcohol dependence can they really predict? Journal of Liver Research, Disorders & Therapy. 2016;2(3):78-81.  https://doi.org/10.15406/jlrdt.2016.02.00028
  43. Fan AZ, Chou SP, Zhang H, et al. Prevalence and Correlates of Past-Year Recovery from DSM-5 Alcohol Use Disorder: Results from National Epidemiologic Survey on Alcohol and Related Conditions-III. Alcoholism, Clinical and Experimental Research. 2019;43(11):2406-2420. https://doi.org/10.1111/acer.14192
  44. Ramsewak S, Putteeraj M, Somanah J. Exploring substance use disorders and relapse in Mauritian male addicts. Heliyon. 2020;6(8):e04731. https://doi.org/10.1016/j.heliyon.2020.e04731
  45. Unsworth DJ, Mathias JL. Traumatic brain injury and alcohol/substance abuse: A Bayesian meta-analysis comparing the outcomes of people with and without a history of abuse. J Clin Exp Neuropsychol. 2017;39(6):547-562.  https://doi.org/10.1080/13803395.2016.1248812
  46. Beaulieu-Bonneau S, St-Onge F, Blackburn MC, et al. Alcohol and Drug Use Before and During the First Year After Traumatic Brain Injury. J Head Trauma Rehabil. 2018;33(3):E51-E60.  https://doi.org/10.1097/HTR.0000000000000341
  47. Guliyev C, İnce-Guliyev E, Ögel K. Predictors of Relapse to Alcohol and Substance Use: Are There Any Differences between 3 and 12 Months after Inpatient Treatment? J Psychoactive Drugs. 2022;54(4):358-367.  https://doi.org/10.1080/02791072.2021.1976887
  48. Senn S, Odenwald M, Sehrig S, et al. Therapeutic success in relapse prevention in alcohol use disorder: the role of treatment motivation and drinking-related treatment goals. J Addict Dis. 2021;39(1):88-95.  https://doi.org/10.1080/10550887.2020.1820810
  49. Kizilkurt OK, Gıynaş FF. Factors affecting treatment motivation among Turkish patients receiving inpatient treatment due to alcohol/substance use disorder. J Ethn Subst Abuse. 2020;19(4):594-609.  https://doi.org/10.1080/15332640.2018.1548324
  50. Fedotov IA, Shustov DI. The phenomenon of attachment to parents, duration of therapeutic remissions and autoaggressive behavior in patients with alcohol dependence. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(1):90-93. (In Russ.). https://doi.org/10.17116/jnevro20161161190-93
  51. Abdin E, Subramaniam M, Vaingankar JA, et al. The role of sociodemographic factors in the risk of transition from alcohol use to disorders and remission in Singapore. Alcohol and Alcoholism. 2014;49(1):103-108.  https://doi.org/10.1093/alcalc/agt126
  52. McCutcheon VV, Kramer JR, Edenberg HJ, et al. Social contexts of remission from DSM-5 alcohol use disorder in a high-risk sample. Alcoholism, Clinical and Experimental Research. 2014;38(7):2015-2023. https://doi.org/10.1111/acer.12434
  53. Dawson DA, Goldstein RB, Grant BF. Rates and correlates of relapse among individuals in remission from DSM-IV alcohol dependence: a 3-year follow-up. Alcohol Clin Exp Res. 2007;31(12):2036-2045. https://doi.org/10.1111/j.1530-0277.2007.00536.x
  54. Petrunko OV, Bryukhanova EN. Factors of long-term remission formation in patients with alcohol dependence. Acta Biomedica Scientifica. 2017;2(5):125-32. (In Russ.). https://doi.org/10.12737/article_5a3a0e7bd7d985.70954570
  55. Odenwald M, Semrau P. Dropout among patients in qualified alcohol detoxification treatment: the effect of treatment motivation is moderated by Trauma Load. Subst Abuse Treat Prev Policy. 2013;8:14.  https://doi.org/10.1186/1747-597X-8-14
  56. Afkar A, Rezvani SM, Sigaroudi AE. Measurement of factors influencing the relapse of addiction: a factor analysis. International Journal High Risk Behaviors & Addiction. 2017;6(3):e32141. https://doi.org/10.5812/ijhrba.32141
  57. Krentzman AR, Cranford JA, Robinson EAR. Long-term increases in purpose in life are associated with remission from alcohol dependence. Alcohol Treat Q. 2015;33:252-269.  https://doi.org/10.1080/07347324.2015.1050924
  58. Andersson HW, Wenaas M, Nordfjærn T. Relapse after inpatient substance use treatment: A prospective cohort study among users of illicit substances. Addictive Behaviors. 2019;90:222-228.  https://doi.org/10.1016/j.addbeh.2018.11.008
  59. Nobatova, VN, Agibalova TV. Analysis of factors influencing the formation of remission in narcological patients. Narkologia. 2020;19(12):89-94. (In Russ.).
  60. Haber JR, Grant JD, Jacob TJ, et al. Alcohol milestones, risk factors, and religion/spirituality in young adult women. J Stud Alcohol Drugs. 2012;73:34-43.  https://doi.org/10.15288/jsad.2012.73.34
  61. Bharat C, Glantz MD, Aguilar-Gaxiola S, et al. Development and evaluation of a risk algorithm predicting alcohol dependence after early onset of regular alcohol use. Addiction. 2023;118(5):954-966.  https://doi.org/10.1111/add.16122
  62. Redmond ML, Buhrmann AS, Fuller-Thomson E. The Continuum of Recovery from Alcohol Dependence: From Addiction Remission to Complete Mental Health. Subst Use Misuse. 2021;56(9):1320-1331. https://doi.org/10.1080/10826084.2021.1922451
  63. Salomón T, Conde K, Cremonte M. Profiles of alcohol use disorder criteria: Help-seeking vs self-achieved remission in Argentinean hospital patients. J Ethn Subst Abuse. 2022;21(3):914-922.  https://doi.org/10.1080/15332640.2020.1803782
  64. Pavlov DG. The influence of individual psychological characteristics on the formation of remission and relapse in patients with alcohol dependence syndrome. Uchenye zapiski SPbGIPSR. 2009;11(1):142-147. (In Russ.).
  65. Belokrylov IV, Kravchenko SL. (2011). Alkogolizm i lichnost’. Alkogolizm: Rukovodstvo dlya vrachey. Moscow, Medical Information Agency, 2011:268-287. (In Russ.).
  66. Igonin AL. The modern concept of treatment of patients with alcoholism and drug addiction. Voprosy narkologii. 1991;3:13-16. (In Russ.).
  67. Altshuler VB. Alkogolizm. Moscow: GEOTAR-Media, 2010. 264 p. (In Russ.).
  68. Rapsey CM, Wells JE, Bharat MC, et al. Transitions Through Stages of Alcohol Use, Use Disorder and Remission: Findings from Te Rau Hinengaro, the New Zealand Mental Health Survey. Alcohol and Alcoholism. 2019;54(1):87-96.  https://doi.org/10.1093/alcalc/agy069
  69. Lebiecka Z, Tyburski E, Skoneczny T, et al. Do Personality, Alcohol Abstinence Self-Efficacy, and Depressive Symptomatology Affect Abstinence Status in Treatment-Seeking Patients with Alcohol Use Disorder? Int. J. Environ Res Public Health. 2022;19(15):9023. https://doi.org/10.3390/ijerph19159023
  70. Tschorn M, Daedelow L, Szalek L, et al. IMAGEN Consortium. Personality, Social Factors, Brain Functioning, Familial Risk, and Trajectories of Alcohol Misuse in Adolescence. JAMA Netw Open. 2024;7(8):e2425114. https://doi.org/10.1001/jamanetworkopen.2024.25114
  71. McCutcheon VV, Grant JD, Heath AC, et al. Environmental influences predominate in remission from alcohol use disorder in young adult twins. Psychological Medicine. 2012;42(11):2421-2431. https://doi.org/10.1017/S003329171200044X
  72. Kwako LE, Patterson J, Salloum IM, Trim RS. Alcohol Use Disorder and Co-Occurring Mental Health Conditions. Alcohol Res. 2019;40(1):arcr.v40.1.00. 
  73. Klimkiewicz A, Klimkiewicz J, Jakubczyk A, et al. Comorbidity of alcohol dependence with other psychiatric disorders. Psychiatr Pol. 2015;49(2):265-94.  https://doi.org/10.12740/PP/25704
  74. Haber PS, Riordan BC, Winter DT, et al. New Australian guidelines for the treatment of alcohol problems: an overview of recommendations. Med J Aust. 2021;215 Suppl 7:S3-S32.  https://doi.org/10.5694/mja2.51254
  75. Brunault P, Lebigre K, Idbrik F, et al. Childhood Trauma Predicts Less Remission from PTSD among Patients with Co-Occurring Alcohol Use Disorder and PTSD. J Clin Med. 2020;9(7):2054. https://doi.org/10.3390/jcm9072054
  76. Lee RS, Oswald LM, Wand GS. Early Life Stress as a Predictor of Co-Occurring Alcohol Use Disorder and Post-Traumatic Stress Disorder. Alcohol Res. 2018;39(2):147-159. 
  77. Tursunkhodzhaeva LA, Mutalibov ShA, Tursunkhodzhaev MH. Reverse clinical dynamics of pathological attraction to alcohol during alcoholic remission. Problemy narkologii. 1989:138-140. (In Russ.).
  78. Jackson KM, Marceau K, Colby SM, et al. Trajectories of early alcohol use milestones: Interrelations among initiation and progression. Alcohol Clin Exp Res. 2021;45(11):2294-2308. https://doi.org/10.1111/acer.14723
  79. Cole F, Benjet C, Ghimire DJ, Axinn WG. Predictors of transitions across stages of alcohol use and disorders in an adult population with heterogeneous ethnic restrictions regarding drinking. Addiction. 2021;116(4):809-818.  https://doi.org/10.1111/add.15221
  80. Witkiewitz K, Litten RZ, Leggio L. Advances in the science and treatment of alcohol use disorder. Sci Adv. 2019;5(9):eaax4043. https://doi.org/10.1126/sciadv.aax4043
  81. Behrendt S, Kuerbis A, Braun-Michl B, et al. Residual alcohol use disorder symptoms after treatment predict long-term drinking outcomes in seniors with DSM-5 alcohol use disorder. Alcohol Clin Exp Res. 2021;45(11):2396-2405. https://doi.org/10.1111/acer.14722
  82. Goh ET, Morgan MY. Review article: pharmacotherapy for alcohol dependence — the why, the what and the wherefore. Aliment Pharmacol. Ther. 2017;45(7):865-882.  https://doi.org/10.1111/apt.13965
  83. Haug S, Eggli P, Schaub MP. Drinking Goals and Their Association With Treatment Retention and Treatment Outcomes Among Clients in Outpatient Alcohol Treatment. Subst Use Misuse. 2017;52(3):313-321.  https://doi.org/10.1080/10826084.2016.1225764
  84. Henssler J, Müller M, Carreira H, et al. Controlled drinking-non-abstinent versus abstinent treatment goals in alcohol use disorder: a systematic review, meta-analysis and meta-regression. Addiction. 2021;116(8):1973-1987. https://doi.org/10.1111/add.15329
  85. Haug S, Castro RP, Eggli P, Schaub MP. Drinking Goal Trajectories and Their Association with Client Characteristics and Outcomes among Clients in Outpatient Alcohol Treatment. Subst Use Misuse. 2018;53(13):2140-2151. https://doi.org/10.1080/10826084.2018.1461222
  86. Haug S, Schaub MP. Treatment outcome, treatment retention, and their predictors among clients of five outpatient alcohol treatment centres in Switzerland. BMC Public Health. 2016;16:581.  https://doi.org/10.1186/s12889-016-3294-4
  87. Mehta K, Hoadley A, Ray LA, et al. Cognitive-Behavioral Interventions Targeting Alcohol or Other Drug Use and Co-Occurring Mental Health Disorders: A Meta-Analysis. Alcohol. 2021;56(5):535-544.  https://doi.org/10.1093/alcalc/agab016
  88. Ray LA, Meredith LR, Kiluk BD, et al. Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020;3(6):e208279. https://doi.org/10.1001/jamanetworkopen.2020.8279
  89. WHO Global Status Report on Alcohol and Health 2014. Geneva: World Health Organization. 2014;376. 
  90. Jonas DE, Amick HR, Feltner C, et. al. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA. 2014;311(18):1889-1900.
  91. Reus VI, Fochtmann LJ, Bukstein O, et al. The American Psychiatric Association Practice guideline for the pharmacological treatment of patients with alcohol use disorder. Am. J. Psychiatry. 2018;175(1):86-90. 
  92. Fischler PV, Soyka M, Seifritz E, Mutschler J. Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review. Front Pharmacol. 2022;13:927703. https://doi.org/10.3389/fphar.2022.927703
  93. Rybakova KV. Pharmacogenetic analysis of the effectiveness of alcohol dependence therapy with pregabalin: analysis of intergenic interaction. Narkologiya. 2019;18(3):33-52 (In Russ.).
  94. Mann K, Bladstrom A, Torup L, et al. Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene. Biol Psychiatry. 2013;73(8):706-713.  https://doi.org/10.1016/j.biopsych.2012.10.020
  95. Gual A, He Y, Torup L, et al. A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence. Eur Neuropsychopharmacol. 2013;23(11):1432-1442. https://doi.org/10.1016/j.euroneuro.2013.02.006
  96. Roerecke M, Gual A, Rehm J. Reduction of alcohol consumption and sub sequent mortality in alcohol use disorders: systematic review and meta- analyses. J Clin Psychiatry. 2013;74(12):1181-1189. https://doi.org/10.4088/jcp.13r08379
  97. Francois C, Laramee P, Rahhali N, et al. A predictive microsimulation model to estimate the clinical relevance of reducing alcohol consumption in alcohol dependence. Eur Addict Res. 2014;20(6):269-284.  https://doi.org/10.1159/000362408
  98. Cousins SJ, Denering L, Crevecoeur-MacPhail D, et al. A demonstration project implementing extended-release naltrexone in Los Angeles County. Subst Abus. 2016;37(1):54-62. 
  99. Pastoor D, Gobburu J. Clinical pharmacology review of escitalopram for the treatment of depression. Expert Opinion on Drug Metabolism & Toxicology. 2014;10(1):121-128. 
  100. Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;391:1357-1366.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.